Philips joins Irish Aerogen for nebulizer license; Oramed snags Australia, Israel patents for oral insulin;

> Philips ($PHG) signed a deal with Galway, Ireland-based devicemaker Aerogen to license Aerogen's homecare nebulizer technology. More

> Oramed ($ORMP) secured a patent in Australia and its home country of Israel for a core concept of its insulin oral delivery. This adds to a list of countries that have allowed the patent, including Japan, China, Russia and New Zealand. Release

> Researchers at Emory University have created a luteolin-delivering nanoparticle that could aid in cancer prevention. More

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.